U.S. markets closed

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.94000.0000 (0.00%)
At close: 4:00PM EDT
1.9100 -0.03 (-1.55%)
After hours: 05:07PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/14/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) -0.53
52-Week Change 3-13.68%
S&P500 52-Week Change 333.47%
52 Week High 34.8900
52 Week Low 31.5500
50-Day Moving Average 32.0337
200-Day Moving Average 32.3644

Share Statistics

Avg Vol (3 month) 3914.73k
Avg Vol (10 day) 3252.6k
Shares Outstanding 516.78M
Implied Shares Outstanding 6N/A
Float 11.46M
% Held by Insiders 123.57%
% Held by Institutions 112.03%
Shares Short (Aug 30, 2021) 4207.37k
Short Ratio (Aug 30, 2021) 40.23
Short % of Float (Aug 30, 2021) 41.47%
Short % of Shares Outstanding (Aug 30, 2021) 41.24%
Shares Short (prior month Jul 29, 2021) 4264.29k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 26, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.27%
Return on Equity (ttm)-84.30%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-4.24M
Diluted EPS (ttm)-0.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.93M
Total Cash Per Share (mrq)0.71
Total Debt (mrq)661.41k
Total Debt/Equity (mrq)6.12
Current Ratio (mrq)20.02
Book Value Per Share (mrq)0.66

Cash Flow Statement

Operating Cash Flow (ttm)-2.16M
Levered Free Cash Flow (ttm)-806.83k